Repeated exposure to drugs of abuse produces specific neuroadaptations in the mesolimbic dopamine system that could alter both the primary and secondary reinforcing properties of the drugs, and contribute to relapse of drug-seeking behavior. In the nucleus accumbens (NAc), some of these neuroadaptations could result from altered gene expression mediated by drug-induced changes in the transcription factors, CREB (cAMP-Response Element Binding protein) and deltaFosB, a Fos-related Antigen (FRA) induced by chronic, but not acute, drug exposure. Similarly, repeated drug exposure produce an up-regulation of GluR1, an AMPA glutamate receptor subunit, in the ventral tegmental area (VTA), and a down-regulation of the GluR2 subunit in the NAc. Our hypothesis is that these neuroadaptations contribute to specific motivational changes associated with drug addiction, for example with sensitization or tolerance to the reinforcing properties of the drugs, or to enhance the ability of drugs, stress, and drug-associated (conditioned) stimuli to trigger relapse of drug-seeking behavior. The proposed studies will test the hypothesis by using animals with genetically altered levels of these target proteins in the VTA and NAc 1) by direct transfection with a viral vector containing the gene for the target protein in rats; and 2) by using mutant mice that lack or over express the gene for the target protein. Preliminary studies demonstrate that these genetically modified animals exhibit altered responses to drugs of abuse in other drug-related behaviors (see Behavioral Core). The studies in Project 4 will extend these studies by testing the effects of genetically modulating the target protein on direct behavioral measures of the primary and secondary reinforcing properties of drugs, and relapse of drug-seeking behavior triggered by drugs, conditioned stimuli, and stress. Some neuroadaptations to chronic drug exposure resemble a neurodegenerative process, and can be prevented or reversed by infusion or neurotrophic factors into the VTA or NAc. Moreover, some of the neuroadaptations mentioned above can be modified by these factors. Preliminary studies have found highly potent actions of neurotrophic factors on drug-related behaviors. Since these various neuroadaptations are hypothesized to contribute to motivations changes associated with drug addiction, the proposed studies will test whether treatment with neurotrophic factors can alter direct behavioral measures of primary and secondary drug reinforcement, and relapse of drug-seeking behavior triggered by drugs, conditioned stimuli, and stress.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
3P01DA008227-06S1
Application #
6296219
Study Section
Project Start
1998-09-30
Project End
1999-06-30
Budget Start
Budget End
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Miller, M L; Ren, Y; Szutorisz, H et al. (2018) Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. Mol Psychiatry 23:1328-1335
Monteggia, Lisa M; Heimer, Hakon; Nestler, Eric J (2018) Meeting Report: Can We Make Animal Models of Human Mental Illness? Biol Psychiatry 84:542-545
Clark, Christopher R; Maile, Makayla; Blaney, Patrick et al. (2018) Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Sci Rep 8:15327
Cates, Hannah M; Heller, Elizabeth A; Lardner, Casey K et al. (2018) Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action via Transcription and Alternative Splicing. Biol Psychiatry 84:167-179
Cahill, M E; Walker, D M; Gancarz, A M et al. (2018) The dendritic spine morphogenic effects of repeated cocaine use occur through the regulation of serum response factor signaling. Mol Psychiatry 23:1474-1486
Hamilton, Peter J; Burek, Dominika J; Lombroso, Sonia I et al. (2018) Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress. Neuropsychopharmacology 43:272-284
Egervari, Gabor; Kozlenkov, Alexey; Dracheva, Stella et al. (2018) Molecular windows into the human brain for psychiatric disorders. Mol Psychiatry :
de la Fuente Revenga, Mario; Ibi, Daisuke; Saunders, Justin M et al. (2018) HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice. Neuroscience 388:102-117
Anderson, Ethan M; Sun, Haosheng; Guzman, Daniel et al. (2018) Knockdown of the histone di-methyltransferase G9a in nucleus accumbens shell decreases cocaine self-administration, stress-induced reinstatement, and anxiety. Neuropsychopharmacology :
Hamilton, Peter J; Lim, Carissa J; Nestler, Eric J et al. (2018) Stereotaxic Surgery and Viral Delivery of Zinc-Finger Epigenetic Editing Tools in Rodent Brain. Methods Mol Biol 1867:229-238

Showing the most recent 10 out of 312 publications